<?xml version="1.0" encoding="UTF-8"?>
<article article-type="research-article" dtd-version="1.3" xml:lang="en" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <front>
    <journal-meta>
      <journal-title-group>
        <journal-title>Journal of Women's Clinical Health Research</journal-title>
      </journal-title-group>
      <issn pub-type="epub">3107-9857</issn>
      <abbrev-journal-title abbrev-type="publisher">JWHS</abbrev-journal-title>
      <publisher>
        <publisher-name>Globalmeetx Publishing, an imprint of Conve International Pvt Ltd</publisher-name>
        <publisher-loc>Visakhapatnam, Andhra Pradesh, India</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Editorial</subject>
        </subj-group>
      </article-categories>
      <article-id pub-id-type="doi">10.67238/jwhs.2026.v2.04</article-id>
      <article-id pub-id-type="publisher-id">JWHS-26-8549</article-id>
      <title-group>
        <article-title>Closing the Gaps in Cervical Cancer Prevention and Early Detection Advancing the WHO Strategy through Improved Awareness, HPV Vaccination, and Screening Uptake</article-title>
      </title-group>
      <pub-date pub-type="epub">
        <day>17</day>
        <month>09</month>
        <year>2026</year>
      </pub-date>
      <volume>2</volume>
      <issue>1</issue>
      <fpage>30</fpage>
      <lpage>31</lpage>
      <counts>
        <page-count count="2"/>
      </counts>
      <history>
        <date date-type="received">
          <day>18</day>
          <month>05</month>
          <year>2026</year>
        </date>
        <date date-type="rev-recd">
          <day>10</day>
          <month>09</month>
          <year>2026</year>
        </date>
        <date date-type="pub">
          <day>17</day>
          <month>09</month>
          <year>2026</year>
        </date>
      </history>
      <permissions>
        <license xlink:href="https://creativecommons.org/licenses/by/4.0/" license-type="open-access">
          <license-p>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <self-uri content-type="pdf" xlink:href="https://www.globalmeetx.com/journals/jwhs/articles/JWHS-26-8549-13.pdf"/>
      <aff id="aff1">
        <institution-wrap>
          <institution>Oman College of Health Sciences North Batinah Branch Oman</institution>
        </institution-wrap>
      </aff>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Al-Marzouqi</surname>
            <given-names>Zalikha Khamis Darwish</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
      </contrib-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <p>Cervical cancer remains one of the few cancers that is largely preventable, yet it continues to affect hundreds of thousands of women worldwide each year[1, 2]. Despite advances in screening, vaccination, and treatment, major disparities in awareness, healthcare access, and preventive service utilization continue to hinder global progress[2]. The burden remains particularly significant in low- and middle-income countries, where women often experience delayed diagnosis and limited access to timely care[2, 3]. </p>
      <p>Persistent infection with high-risk human papillomavirus (HPV) is the primary cause of cervical cancer, making HPV vaccination and regular screening essential public health interventions[4]. Recognizing this opportunity, the World Health Organization launched the global strategy to eliminate cervical cancer as a public health problem through the 90–70–90 targets, which aim to improve vaccination coverage, screening uptake, and access to treatment[1]. Although this initiative represents a major milestone in women’s health, achieving these goals remains challenging in many healthcare settings[5]. Barriers to cervical cancer prevention extend beyond healthcare infrastructure alone. Fear, stigma, cultural sensitivities, misinformation, and limited health literacy continue to influence women’s participation in screening and vaccination programs[3]. Misconceptions regarding HPV vaccination safety and concerns surrounding reproductive health discussions may further reduce public acceptance of preventive interventions[6]. In many communities, women continue to avoid screening because of embarrassment, anxiety, or inadequate understanding of the importance of early detection[3]. </p>
      <p>Healthcare professionals play a critical role in addressing these challenges. Nurses, physicians, midwives, and public health practitioners are often the primary source of health information for women and families. Providing culturally sensitive education, correcting misconceptions, and promoting evidence-based communication can significantly improve public confidence in vaccination and screening programs. Public health campaigns, school-based education, and digital awareness initiatives may further strengthen community engagement and improve health literacy. Expanding equitable access to affordable HPV vaccination and cervical cancer screening services should remain a global public health priority[1]. Innovative approaches such as self-sampling HPV tests, telehealth support, and community outreach programs may help improve access among underserved populations[7]. At the same time, policymakers and healthcare systems must continue investing in preventive healthcare infrastructure and workforce development to support sustainable cervical cancer prevention strategies.  The second shift is the shift of male fertility from the wings to centre stage in fertility care. In roughly half of all cases of infertility, a male factor is present, either alone or together with another factor. In the future, fertility clinics will not focus on women when it comes to investigation, counselling and treatment planning. A semen analysis alone will not do. Couples should take into account DNA fragmentation, oxidative stress, lifestyle, endocrine status, varicocele, genetics, infections, environmental exposure and sexual health in fertility planning.</p>
    </sec>
    <sec>
      <title>CONFLICT OF INTEREST</title>
      <p>The author declares no conflict of interest.</p>
    </sec>
    <sec>
      <title>FUNDING</title>
      <p>No funding was received for this work.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <ref id="ref1">
        <label>1</label>
        <mixed-citation>REFERENCES</mixed-citation>
      </ref>
      <ref id="ref2">
        <label>2</label>
        <mixed-citation>World Health Organization. Global strategy to accelerate the elimination of cervical cancer as a public health problem. World Health Organization; 2020</mixed-citation>
      </ref>
      <ref id="ref3">
        <label>3</label>
        <mixed-citation>Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209-249</mixed-citation>
      </ref>
      <ref id="ref4">
        <label>4</label>
        <mixed-citation>Arbyn M, Weiderpass E, Bruni L, et al. Estimates of incidence and mortality of cervical cancer in 2018: A worldwide analysis. Lancet Glob Health. 2020;8(2):e191-e203</mixed-citation>
      </ref>
      <ref id="ref5">
        <label>5</label>
        <mixed-citation>Bruni L, Saura-Lázaro A, Montoliu A, et al. HPV vaccination introduction worldwide and WHO and UNICEF estimates of national HPV immunization coverage 2010-2019. Prev Med. 2021;144:106399</mixed-citation>
      </ref>
      <ref id="ref6">
        <label>6</label>
        <mixed-citation>Canfell K. Towards the global elimination of cervical cancer. Papillomavirus Res. 2019;8:100170</mixed-citation>
      </ref>
      <ref id="ref7">
        <label>7</label>
        <mixed-citation>Cohen PA, Jhingran A, Oaknin A, Denny L. Cervical cancer. Lancet. 2019;393(10167):169-182</mixed-citation>
      </ref>
      <ref id="ref8">
        <label>8</label>
        <mixed-citation>Gupta S, Palmer C, Bik EM, et al. Self-sampling for human papillomavirus testing: Increased cervical cancer screening participation and incorporation in international screening programs. Front Public Health. 2018;6:77</mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
